Joyce James
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 9
- Genetics 11
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Robert C. Armstrong (8 shared papers)Mark J. Levis (4 shared papers)Ruwanthi N. Gunawardane (5 shared papers)Patrick P. Zarrinkar (7 shared papers)Shripad S. Bhagwat (6 shared papers)Kelly G. Sprankle (3 shared papers)Hitesh Patel (3 shared papers)Michael F. Gardner (6 shared papers)
- Journals
- Blood (7 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesJapanNew Zealand
In The Last Decade
Joyce James
19 papers receiving 1.1k citations
Joyce James's Hit Papers
Peers
Comparison fields: 5 of 53
- Hematology 787
- Genetics 323
- Molecular Biology 452
- Oncology 118
- Organic Chemistry 129
Countries citing papers authored by Joyce James
This map shows the geographic impact of Joyce James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce James more than expected).
Fields of papers citing papers by Joyce James
This network shows the impact of papers produced by Joyce James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce James. The network helps show where Joyce James may publish in the future.
Co-authors
The 25 scholars most cited alongside Joyce James, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML) Hit paper breakdown → | 2009 | 479 |
| 2 | 2013 | 280 | |
| 3 | 2009 | 170 | |
| 4 | 2009 | 54 | |
| 5 | 2009 | 27 | |
| 6 | 2016 | 24 | |
| 7 | 2008 | 13 | |
| 8 | 2011 | 13 | |
| 9 | 2012 | 10 | |
| 10 | 2007 | 7 | |
| 11 | 2009 | 7 | |
| 12 | 2005 | 6 | |
| 13 | 2009 | 6 | |
| 14 | 2012 | 5 | |
| 15 | 2011 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2019 | 2 | |
| 18 | Abstract #1787: Characterization of the biochemical and cellular activity of the second-generation FLT3 inhibitor AC220 | 2009 | 1 |
| 19 | 2008 | 1 |
About Joyce James
Joyce James is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Protein Degradation and Inhibitors (2 papers), Cell Adhesion Molecules Research (2 papers), Neuropeptides and Animal Physiology (2 papers), HER2/EGFR in Cancer Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (787 citations), Genetics (323 citations), Molecular Biology (452 citations), Oncology (118 citations) and Organic Chemistry (129 citations). Joyce James has collaborated with scholars based in United States, Japan and New Zealand. Frequent co-authors include Robert C. Armstrong, Mark J. Levis, Ruwanthi N. Gunawardane, Patrick P. Zarrinkar, Shripad S. Bhagwat, Kelly G. Sprankle, Hitesh Patel, Michael F. Gardner, Qi Chao and Merryl Cramer. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Cancer Research, Journal of Clinical Oncology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.